1-4 of 4
Shivani Pandya
Close
Sort by
Journal Articles

Changes in the Incidence and Overall Survival of Patients with Myeloproliferative Neoplasms between 2002 and 2016 in the United States

Srdan Verstovsek, MD PhD, Jingbo Yu, MD PhD, Robyn M. Scherber, MD, Shivani Pandya, MS, Christopher Dieyi, MPH, Chien-Cheng Chen, MS, Shreekant Parasuraman, BPharm, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-141090
Published: 2020
Journal Articles

Burden of CRAB Events By Relapse in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Stem Cell Transplant

Shivani Pandya, Zoe Clancy, Sulena Shrestha, MPH, Li Wang, PhD, Onur Baser
Journal: Blood
Blood (2018) 132 (Supplement 1): 4770.
https://doi.org/10.1182/blood-2018-99-111236
Published: 2018
Journal Articles

Treatment Patterns Among Newly Diagnosed Multiple Myeloma Patients in the United States Veteran Population (2010-2015)

Kejal Parikh, Shivani Pandya, MS, Safiya Abouzaid, Onur Baser, MS, PhD, Lin Xie, MA, MS, Manali I. Patel, MD MPH, MS
Journal: Blood
Blood (2016) 128 (22): 5952.
https://doi.org/10.1182/blood.V128.22.5952.5952
Published: 2016
Journal Articles

Real World Treatment Outcomes and Cost Among Newly-Diagnosed Multiple Myeloma Patients Treated with Bortezomib and Dexamethasone in Combination with Cyclophosphamide or Lenalidomide

Lin Xie, MA, MS, Kejal Parikh, Safiya Abouzaid, Shivani Pandya, MS, Onur Baser, MS, PhD, Manali I. Patel, MD MPH, MS
Journal: Blood
Blood (2016) 128 (22): 5924.
https://doi.org/10.1182/blood.V128.22.5924.5924
Published: 2016